IGC Pharma (IGC) Return on Sales (2010 - 2025)
IGC Pharma (IGC) posted quarterly Return on Sales of 0.1% for Q3 2025, down 5.0% year-over-year from 0.1% in Q3 2024, and down 95.57% quarter-over-quarter from 0.05% in Q2 2025.
IGC Pharma (IGC) Return on Sales (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported Return on Sales for 16 consecutive years, with 0.1% the latest figure, recorded in Q3 2025.
- In Q3 2025, Return on Sales fell 5.0% year-over-year to 0.1%; the TTM figure through Sep 2025 stood at 0.06% (up 6.0% YoY), while the FY2026 annual figure was 0.08%, down 4.0% from the prior year.
- Return on Sales fell to 0.1% in Q3 2025 per IGC's latest filing, from 0.05% in the prior quarter.
- Across five years, Return on Sales topped out at 0.04% in Q1 2025 and bottomed at 0.78% in Q3 2021.
- Historically, Return on Sales has averaged 0.18% across 5 years, with a median of 0.1% in 2023.
- Annual changes were most pronounced in 2021 — Return on Sales tumbled 64 bps — and 2022, when it surged 65 bps.
- IGC Pharma's Return on Sales stood at 0.17% in 2021, then jumped by 60 bps to 0.07% in 2022, then plunged by 304 bps to 0.27% in 2023, then jumped by 74 bps to 0.07% in 2024, then slumped by 34 bps to 0.1% in 2025.
- Business Quant data shows IGC's Return on Sales at 0.1% in Q3 2025, 0.05% in Q2 2025, and 0.04% in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.10% |
| Jun 30, 2025 | -0.05% |
| Mar 31, 2025 | -0.04% |
| Dec 31, 2024 | -0.07% |
| Sep 30, 2024 | -0.04% |
| Jun 30, 2024 | -0.09% |
| Mar 31, 2024 | -0.15% |
| Dec 31, 2023 | -0.27% |
| Sep 30, 2023 | -0.08% |
| Jun 30, 2023 | -0.04% |
| Mar 31, 2023 | -0.10% |
| Dec 31, 2022 | -0.07% |
| Sep 30, 2022 | -0.12% |
| Jun 30, 2022 | -0.13% |
| Mar 31, 2022 | -0.54% |
| Dec 31, 2021 | -0.17% |
| Sep 30, 2021 | -0.78% |
| Jun 30, 2021 | -0.23% |
| Mar 31, 2021 | -0.36% |
| Dec 31, 2020 | -0.22% |